{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:56:54Z","timestamp":1794887814225,"version":"4.9.1"},"reference-count":25,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,12]]},"DOI":"10.1182\/bloodadvances.2025015894","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:56:52Z","timestamp":1745416612000},"page":"3689-3693","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["T-cell dysfunction during blinatumomab therapy in pediatric acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4393-2927","authenticated-orcid":false,"given":"Julie","family":"Ma","sequence":"first","affiliation":[{"name":"1Cancer and Blood Disease Institute, Department of Pediatrics, Children\u2019s Hospital Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Luong","sequence":"additional","affiliation":[{"name":"2The Saban Research Institute, Children\u2019s Hospital Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8362-549X","authenticated-orcid":false,"given":"Andrew","family":"Doan","sequence":"additional","affiliation":[{"name":"1Cancer and Blood Disease Institute, Department of Pediatrics, Children\u2019s Hospital Los Angeles, Los Angeles, CA"},{"name":"3Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsen Yin","family":"Lin","sequence":"additional","affiliation":[{"name":"2The Saban Research Institute, Children\u2019s Hospital Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2500-1993","authenticated-orcid":false,"given":"Lingyun","family":"Ji","sequence":"additional","affiliation":[{"name":"4Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8000-7939","authenticated-orcid":false,"given":"Cassandra P.","family":"Wang","sequence":"additional","affiliation":[{"name":"1Cancer and Blood Disease Institute, Department of Pediatrics, Children\u2019s Hospital Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Jae","family":"Yoon","sequence":"additional","affiliation":[{"name":"1Cancer and Blood Disease Institute, Department of Pediatrics, Children\u2019s Hospital Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Rushing","sequence":"additional","affiliation":[{"name":"1Cancer and Blood Disease Institute, Department of Pediatrics, Children\u2019s Hospital Los Angeles, Los Angeles, CA"},{"name":"5Department of Pharmacy, Children\u2019s Hospital Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh","family":"Duong","sequence":"additional","affiliation":[{"name":"2The Saban Research Institute, Children\u2019s Hospital Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Villa","sequence":"additional","affiliation":[{"name":"1Cancer and Blood Disease Institute, Department of Pediatrics, Children\u2019s Hospital Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chintan","family":"Parekh","sequence":"additional","affiliation":[{"name":"1Cancer and Blood Disease Institute, Department of Pediatrics, Children\u2019s Hospital Los Angeles, Los Angeles, CA"},{"name":"3Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"issue":"18","key":"2025081209564184800_bib1","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2010.32.7270","article-title":"Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival","volume":"29","author":"Topp","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9","key":"2025081209564184800_bib2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2021.0987","article-title":"Effect of blinatumomab vs chemotherapy on event-free survival among children with high-risk first-relapse B-cell acute lymphoblastic leukemia: a randomized clinical trial","volume":"325","author":"Locatelli","year":"2021","journal-title":"JAMA"},{"issue":"9","key":"2025081209564184800_bib3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/ajh.26634","article-title":"Blinatumomab is associated with favorable outcomes in patients with B-cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10-4 and higher","volume":"97","author":"Jabbour","year":"2022","journal-title":"Am J Hematol"},{"issue":"9","key":"2025081209564184800_bib4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jama.2021.0669","article-title":"Effect of postreinduction therapy consolidation with blinatumomab vs chemotherapy on disease-free survival in children, adolescents, and young adults with first relapse of B-cell acute lymphoblastic leukemia: a randomized clinical trial","volume":"325","author":"Brown","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"2025081209564184800_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ajh.24987","article-title":"Outcome of patients with relapsed\/refractory acute lymphoblastic leukemia after blinatumomab failure: no change in the level of CD19 expression","volume":"93","author":"Jabbour","year":"2018","journal-title":"Am J Hematol"},{"issue":"10","key":"2025081209564184800_bib6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.2022015956","article-title":"T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals","volume":"140","author":"Philipp","year":"2022","journal-title":"Blood"},{"issue":"9","key":"2025081209564184800_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2411680","article-title":"Blinatumomab in standard-risk B-cell acute lymphoblastic leukemia in children","volume":"392","author":"Gupta","year":"2025","journal-title":"N Engl J Med"},{"issue":"4","key":"2025081209564184800_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa2312948","article-title":"Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults","volume":"391","author":"Litzow","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"2025081209564184800_bib22","doi-asserted-by":"crossref","first-page":"eaai8593","DOI":"10.1126\/sciimmunol.aai8593","article-title":"The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness","volume":"1","author":"Wu","year":"2016","journal-title":"Sci Immunol"},{"issue":"4","key":"2025081209564184800_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1158\/2326-6066.CIR-23-0517","article-title":"CD4+ regulatory T cells in human cancer: subsets, origin, and molecular regulation","volume":"12","author":"Swatler","year":"2024","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"2025081209564184800_bib24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","article-title":"Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"issue":"4","key":"2025081209564184800_bib25","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4049\/jimmunol.1200750","article-title":"Id2 influences differentiation of killer cell lectin-like receptor G1(hi) short-lived CD8+ effector T cells","volume":"190","author":"Knell","year":"2013","journal-title":"J Immunol"},{"key":"2025081209564184800_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"2025081209564184800_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/bjh.19104","article-title":"Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: a campus ALL study","volume":"203","author":"Ocadlikova","year":"2023","journal-title":"Br J Haematol"},{"issue":"1","key":"2025081209564184800_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/imr.12796","article-title":"mTOR and other effector kinase signals that impact T cell function and activity","volume":"291","author":"Myers","year":"2019","journal-title":"Immunol Rev"},{"issue":"1","key":"2025081209564184800_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12929-024-01009-6","article-title":"Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer","volume":"31","author":"Kuo","year":"2024","journal-title":"J Biomed Sci"},{"issue":"1","key":"2025081209564184800_bib13","doi-asserted-by":"crossref","first-page":"e001688","DOI":"10.1136\/jitc-2020-001688","article-title":"Deletion of Cbl-b inhibits CD8+ T-cell exhaustion and promotes CAR T-cell function","volume":"9","author":"Kumar","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"6","key":"2025081209564184800_bib14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.immuni.2012.08.021","article-title":"Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory","volume":"37","author":"Doering","year":"2012","journal-title":"Immunity"},{"issue":"7926","key":"2025081209564184800_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41586-022-05105-1","article-title":"MYB orchestrates T cell exhaustion and response to checkpoint inhibition","volume":"609","author":"Tsui","year":"2022","journal-title":"Nature"},{"issue":"1","key":"2025081209564184800_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1074-7613(03)00351-0","article-title":"Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2","volume":"20","author":"Carpino","year":"2004","journal-title":"Immunity"},{"issue":"6","key":"2025081209564184800_bib17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41590-020-0643-3","article-title":"Sestrins induce natural killer function in senescent-like CD8+ T cells","volume":"21","author":"Pereira","year":"2020","journal-title":"Nat Immunol"},{"issue":"2","key":"2025081209564184800_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2011.05.017","article-title":"Tight regulation of memory CD8(+) T cells limits their effectiveness during sustained high viral load","volume":"35","author":"West","year":"2011","journal-title":"Immunity"},{"issue":"7","key":"2025081209564184800_bib19","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.4049\/jimmunol.1001783","article-title":"Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults","volume":"186","author":"Duraiswamy","year":"2011","journal-title":"J Immunol"},{"key":"2025081209564184800_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virol.2014.12.033","article-title":"T cell exhaustion during persistent viral infections","volume":"479-480","author":"Kahan","year":"2015","journal-title":"Virology"},{"issue":"4","key":"2025081209564184800_bib21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/ajh.27227","article-title":"Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia","volume":"99","author":"Jabbour","year":"2024","journal-title":"Am J Hematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/15\/3689\/2403788\/blooda_adv-2025-015894-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/15\/3689\/2403788\/blooda_adv-2025-015894-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T13:56:51Z","timestamp":1755007011000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/15\/3689\/536989\/T-cell-dysfunction-during-blinatumomab-therapy-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":25,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025015894","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8,12]]},"published":{"date-parts":[[2025,7,23]]}}}